Anticancer effects of imidazole nucleus in hepatocellular carcinoma cell lines via the inhibition of AKT and ERK1/2 signaling pathways

被引：0
|
作者：
Erkan Kahraman
Erdem Göker
机构：
[1] Ege University,Research and Application Center of Individualized Medicine
[2] Ege University,Atatürk Vocational School of Health Services
[3] Ege University,Medical Oncology, Faculty of Medicine
来源：
Molecular Biology Reports | 2022年 / 49卷
关键词：
Imidazole; Hepatocellular carcinoma; Cancer; Cancer drugs; Liver cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4377 / 4388
页数：11
相关论文
共 50 条
  • [1] Anticancer effects of imidazole nucleus in hepatocellular carcinoma cell lines via the inhibition of AKT and ERK1/2 signaling pathways
    Kahraman, Erkan
    Goker, Erdem
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (06) : 4377 - 4388
  • [2] Activation of ETA Receptor by Endothelin-1 Induces Hepatocellular Carcinoma Cell Migration and Invasion via ERK1/2 and AKT Signaling Pathways
    Cong, Ning
    Li, Zhongmin
    Shao, Wenbo
    Li, Jinpeng
    Yu, Shui
    JOURNAL OF MEMBRANE BIOLOGY, 2016, 249 (1-2): : 119 - 128
  • [3] Activation of ETA Receptor by Endothelin-1 Induces Hepatocellular Carcinoma Cell Migration and Invasion via ERK1/2 and AKT Signaling Pathways
    Ning Cong
    Zhongmin Li
    Wenbo Shao
    Jinpeng Li
    Shui Yu
    The Journal of Membrane Biology, 2016, 249 : 119 - 128
  • [4] Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells
    Zhao, Yuwan
    Tang, Huancheng
    Zeng, Xin
    Ye, Dongcai
    Liu, Jianjun
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 98 : 36 - 44
  • [5] Synergistic effects of snail and quercetin on renal cell carcinoma Caki-2 by altering AKT/mTOR/ERK1/2 signaling pathways
    Meng, Fan-Dong
    Li, Yan
    Tian, Xin
    Ma, Ping
    Sui, Cheng-Guang
    Fu, Li-Ye
    Jiang, You-Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 6157 - 6168
  • [6] HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways
    Tianchi Chen
    Hechen Huang
    Yuan Zhou
    Lei Geng
    Tian Shen
    Shengyong Yin
    Lin Zhou
    Shusen Zheng
    Journal of Experimental & Clinical Cancer Research, 37
  • [7] Cyclovirobuxine D Exerts Anticancer Effects by Suppressing the EGFR-FAK-AKT/ERK1/2-Slug Signaling Pathway in Human Hepatocellular Carcinoma
    Zhang, Jiuwei
    Chen, Yaodong
    Lin, Jing
    Jia, Ruimei
    An, Tingting
    Dong, Tianxiu
    Zhang, Yu
    Yang, Xiuhua
    DNA AND CELL BIOLOGY, 2020, 39 (03) : 355 - 367
  • [8] HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways
    Chen, T.
    Zheng, S.
    TRANSPLANTATION, 2019, 103 (08) : 323 - 323
  • [9] HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways
    Chen, Tianchi
    Huang, Hechen
    Zhou, Yuan
    Geng, Lei
    Shen, Tian
    Yin, Shengyong
    Zhou, Lin
    Zheng, Shusen
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [10] Inhibition of ERK1/2 Signaling Impairs the Promoting Effects of TGF-β1 on Hepatocellular Carcinoma Cell Invasion and Epithelial-Mesenchymal Transition
    Liu, Ling
    Li, Nianfeng
    Zhang, Qi
    Zhou, Jixiang
    Lin, Ling
    He, Xinxin
    ONCOLOGY RESEARCH, 2017, 25 (09) : 1607 - 1616
12345